Related Experiment Video

Updated: Jun 27, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Trends and disparities in lipoprotein(a) testing in a large integrated US health system, 2000-23

Christian C Faaborg-Andersen1, So Mi Jemma Cho2, Pradeep Natarajan1,2,3

  • 1Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

European Journal of Preventive Cardiology
|April 25, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.1K

Related Experiment Videos

Last Updated: Jun 27, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.1K

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

156
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
156

Articles linked to this work by shared authors, journal, and citation graph.

Machine learning-driven spleen imaging and genomics uncover a splenic connection to coronary artery disease.

Science translational medicine·2026

Genetic evidence supports the combined targeting of lipoprotein(a) and LDL cholesterol to reduce coronary artery disease risk.

Nature cardiovascular research·2026

Clonal haematopoiesis and cardiovascular-kidney-metabolic syndrome: a cohort study.

European heart journal·2026

Platelet Reactivity and Sex Differences: Clinical Implications for Women.

Circulation research·2026

Plasma infrared molecular fingerprinting stratifies residual risk in coronary artery disease and reflects clonal haematopoiesis-associated biology.

European heart journal·2026

A Bayesian framework for longitudinal EHR and genetic discovery.

Nature·2026

Effectiveness, safety, costs, and delivery considerations of exercise-based cardiac rehabilitation in low- and middle-income countries: A systematic review and meta-analysis of randomised controlled trials.

European journal of preventive cardiology·2026

Self-monitoring patterns after acute coronary syndrome: behavioural markers for secondary prevention.

European journal of preventive cardiology·2026

The Role of Psychological Stress in Atrial Fibrillation: Completing the Translational Circle from Molecular Mechanisms to Citizen Science.

European journal of preventive cardiology·2026

The Transition from Stage A to Stage B of Heart Failure: Risk Factors, Promoting Factors, and Opportunities for Prevention-An Update from the Italian Society of Cardiology Working Group on Heart Failure.

European journal of preventive cardiology·2026

Lipid lowering therapy in venous thromboembolism. A Clinical Consensus Statement of the ESC Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, and the European Society of Vascular Medicine (ESVM).

European journal of preventive cardiology·2026

Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Incident Atrial Fibrillation in Type 2 Diabetes: A Population-Based Target Trial Emulation.

European journal of preventive cardiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us